SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 40,200
+1,400 (3.61%)
At close: May 8, 2025, 3:30 PM KST
SK bioscience Revenue
In the year 2024, SK bioscience had annual revenue of 267.55B KRW, down -27.59%. SK bioscience had revenue of 156.85B in the quarter ending December 31, 2024, with 73.11% growth.
Revenue
267.55B
Revenue Growth
-27.59%
P/S Ratio
11.80
Revenue / Employee
271.90M
Employees
984
Market Cap
3,158.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 267.55B | -101.96B | -27.59% |
| Dec 31, 2023 | 369.51B | -87.22B | -19.10% |
| Dec 31, 2022 | 456.73B | -472.28B | -50.84% |
| Dec 31, 2021 | 929.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition